Literature DB >> 1339242

The role of plasminogen activation in smooth muscle cell migration after arterial injury.

C L Jackson1, M A Reidy.   

Abstract

The migration of smooth muscle cells from the media to the intima that occurs after balloon catheter injury to the rat common carotid artery has been quantified by an electron microscopic surveying technique. These vessels have also been assayed for plasminogen-activator activity, which was found to rise sharply 4 days after balloon injury. At this time point smooth muscle cells begin to migrate in appreciable numbers. In order to investigate whether there is a causal relationship between plasminogen-activator activity and smooth muscle cell migration, animals were dosed with tranexamic acid. This synthetic inhibitor of plasmin activity reduced smooth muscle cell migration by 73% (p < 0.05), indicating that plasmin activity is necessary for migration after balloon injury. Lisinopril, an inhibitor of angiotensin-converting enzyme, inhibited smooth muscle cell migration after balloon injury by 78% (p < 0.01) but did not influence plasminogen-activator activity. Taken together, these results show that plasmin is a necessary but not sufficient component in the pathway that leads to smooth muscle cell migration after balloon catheter injury in the rat.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1339242     DOI: 10.1111/j.1749-6632.1992.tb51606.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  12 in total

1.  Urokinase plasminogen activator induces human smooth muscle cell migration and proliferation via distinct receptor-dependent and proteolysis-dependent mechanisms.

Authors:  V Stepanova; S Mukhina; E Köhler; T J Resink; P Erne; V A Tkachuk
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

2.  Squat like a toad close at the ear of Eve.

Authors:  C A Hales
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

3.  Sequence-independent inhibition of in vitro vascular smooth muscle cell proliferation, migration, and in vivo neointimal formation by phosphorothioate oligodeoxynucleotides.

Authors:  W Wang; H J Chen; A Schwartz; P J Cannon; C A Stein; L E Rabbani
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

4.  Impaired arterial neointima formation in mice with disruption of the plasminogen gene.

Authors:  P Carmeliet; L Moons; V Ploplis; E Plow; D Collen
Journal:  J Clin Invest       Date:  1997-01-15       Impact factor: 14.808

5.  Identification of a BamHI Polymorphism for the Urokinase Gene Associated with Symptomatic Coronary Artery Disease.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-05       Impact factor: 2.300

6.  Phosphorothioate Oligodeoxynucleotide Inhibition of Restenosis.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-05       Impact factor: 2.300

7.  Interleukin-4 Modulation of Platelet-Derived Growth Factor-Induced Smooth Muscle Cell Urokinase Plasminogen Activator.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-05       Impact factor: 2.300

8.  Intracellular localization of Cthrc1 characterizes differentiated smooth muscle.

Authors:  Renée J Leclair; Qiaozeng Wang; Meredith A Benson; Igor Prudovsky; Volkhard Lindner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-05-08       Impact factor: 8.311

9.  Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor.

Authors:  J I Jones; T Prevette; A Gockerman; D R Clemmons
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

10.  [The effect of intraoperative high-dose tranexamic acid on blood loss after operation for acute aortic dissection].

Authors:  Y Shimamura; M Nakajima; T Hirayama; H Misumi; T Shimokawa; H Uesugi; K Uemura
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.